MYC and breast carcinoma: Such a regulatory mechanism has been observed in, e.g., breast cancer, where high CRNDE expression diminished the level of miR-136, thus activating the Wnt/β-catenin pathway, contributing to the up-regulation of c-Myc and cyclin D1 and resulting in increased rate of cancer cell proliferation [20].